GLP1R and posterior cortical atrophy: In summary, while preclinical studies have shown promising results, with GLP-1-RA inhibiting cancer cell proliferation and showing synergistic effects when combined with Metformin or RT, clinical data on its impact on PCa outcomes are currently insufficient.